Wednesday, September 28, 2022
HomePress ReleaseEIN PresswireCardiac PoC Testing Devices Market Generated Opportunities, Future Scope 2021-2028 | Abbott...

Cardiac PoC Testing Devices Market Generated Opportunities, Future Scope 2021-2028 | Abbott Laboratories,., BG Medicine,


Cardiac PoC Testing Devices

SEATTLE , WASHINGTON, UNITED STATES, December 10, 2021 /EINPresswire.com/ — Global Cardiac POC Testing Devices Market

Overview:

Cardiac POC is a medical test, which is carried out at or near the point-of-care of a patient. It is a blood test used to detect blood coagulation and cholesterol. Cardiac POC testing devices help doctors check for excessive bleeding (inside blood vessel) as well as the risk of developing thrombosis, which may lead to heart failure. Furthermore, Cardiac POC tests, such as troponin and brain natriuretic peptide analysis test, help identify cardiovascular disorders such as heart failure, myocardial infarction, and coronary artery disease, among others. The aforementioned tests help reduce the time taken to extract data/reports. Cardiac POC testing devices help reduce turnaround time, allowing immediate response and effective management of heart diseases.

As per the World Health Organization (WHO), one third of cases of ischemic heart disease are caused by high cholesterol levels. Increase in blood coagulants and cholesterol level is expected to cause cardiovascular diseases. For instance, as reported by the WHO, in 2016, more than 29 million people were suffering from cardiovascular disorders and over 2.5 million people died due to cardiovascular disorders. Cardiac POC testing devices help detect heart ailments.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/192

Competitive Landscape:

Key players operating in the global cardiac POC testing devices market are Medtronic Inc., Roche Diagnostics, Seimens Healthineers, BG Medicine Inc., and Abbott Laboratories.

Drivers:

High prevalence or incidence of cardiovascular diseases (CVDs) across the globe is expected to boost the growth of the global cardiac POC testing devices market over the forecast period. For instance, according to the FH Foundation, 2015, familial hypercholesterolemia (FH) is a genetic disorder that affects around 1 in 200-500 people worldwide. Thus, with the increasing prevalence, the demand for cardiac POC testing devices is also increasing.

Moreover, as reported by WHO, in 2013, around 33.5 million people worldwide suffered from coronary artery disease, which leads to heart attack. Moreover, in 2015, the U.S. government implemented the Patient Protection and Affordable Care Act under the Hospital Readmissions Reduction Program to impose penalties on hospitals. The U.S. government reduced Medicare payments per patient by 1-2% for re-hospitalization within 30 days. This in turn is also expected to aid in the growth of the market.

Furthermore, growing geriatric population worldwide and cost-effective diagnosis of chronic ailments in rural areas are some major factors expected to propel growth of the global cardiac POC testing devices market. Aging can cause changes in the heart and blood vessels that may increase the risk of developing cardiovascular disease.

Christmas Sale is Live!!!!

Buy Now and Get 25-30% Discount on This Report

Buy-Now this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/192

Market Taxonomy:

By Product Type:

Cardiac Markers Test
Analyzers

By End user:

Research Laboratories
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories and Others)

By Region:

North America
Latin America
Asia Pacific
Europe
Middle East
Africa

Regional Insights:

Asia Pacific is expected to witness robust growth in the global cardiac POC testing devices market due to the high of cardiovascular diseases, increasing purchasing power, and growing population in this region.

Key Developments:

Market player are adopting various inorganic strategies, such as product launch, mergers and acquisitions, etc., to increase their market share and to strengthen their product portfolio. For instance, in July 2017, Abbott Laboratories launched a software firmware, which is embedded in the cardiac testing device. Moreover, in January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction is an important part of the company’s ongoing effort to develop a strong, diverse portfolio of devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/192

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact US:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other





Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular